Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Recent Posts
- Stock futures fall ahead of key earnings week: Live updates
- U.S. puts Colombia tariff, sanctions threat on hold after deportations deal
- Chinese AI applications now have bigger aims — they’re looking beyond chatbots
- Coffee, crude oil and cut flowers: Here are the Colombian goods you may be paying more for under Trump’s tariffs
- Perplexity AI revises Tiktok merger proposal that could give the U.S. government a 50% stake